On March 17, 2021, the U.S. Environmental Protection Agency (EPA) announced the issuance of the final guidance document entitled "Guidance for Waiving Acute Dermal Toxicity Tests for Pesticide ...
The committee explored whether DOD could adopt a modern testing strategy for the prediction of acute toxicity. 3 In particular, the committee’s statement of task required a focus on the assessment of ...
DOD needs to understand the relative threat of the increasingly long list of registered chemical substances, particularly in terms of potential acute hazard. To help DOD achieve its goal to protect ...
Toxicity-testing strategies designed to generate information on potential hazards or risks posed by environmental agents have evolved in response to legislative mandates, scientific developments, and ...
Vancouver, British Columbia--(Newsfile Corp. - March 26, 2026) - RZOLV Technologies Inc. (TSXV: RZL) (OTCQB: RZOLF) ("RZOLV" or the "Company") today announced the results of an ecotoxicity report ...
Biocompatibility testing is a necessary part of any medical device validation process. It is governed by FDA’s ISO 10993 guidance document, a seemingly rigid statement that provides a general matrix ...
RZOLV Technologies Inc. (TSXV: RZL) (OTCQB: RZOLF) ("RZOLV" or the "Company") today announced the results of an ecotoxicity report prepared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results